Position in EXEL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,008,543
+$187,500 QoQ
Shares Held
18,536
-3.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#338
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $12,966,883 across 12 Biotechnology names. EXEL ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,767 | $3,361,371 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,641 | $1,646,769 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
33,276 | $1,177,637 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
4,627 | $1,114,968 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
18,536 | $1,008,543 | |
| 6 | CYTK |
Cytokinetics Inc
|
10,012 | $852,922 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,423 | $849,578 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
14,278 | $816,987 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,008,543 | 18,536 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $821,043 | 19,143 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $856,394 | 19,539 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $832,649 | 20,161 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $915,453 | 20,768 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $784,771 | 21,256 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $718,913 | 21,589 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $575,596 | 22,181 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $522,023 | 23,232 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $591,660 | 24,933 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $629,569 | 26,243 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $589,207 | 26,966 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $554,342 | 29,008 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $572,886 | 29,515 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $475,441 | 29,641 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $460,803 | 29,388 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $608,776 | 29,240 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $643,578 | 28,389 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $516,483 | 28,254 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $597,289 | 28,254 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $524,754 | 28,801 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $664,349 | 29,409 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $590,238 | 29,409 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $733,695 | 30,008 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $737,316 | 31,058 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $537,143 | 31,193 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||